On July 29, 2026, the FAA added a new AME Assisted Special Issuance (AASI) pathway for pilots and air traffic control specialists with anxiety, depression, and related conditions. The FAA refers to this new protocol as PATH.
This is a meaningful change. For an eligible airman whose FAA Authorization specifically approves AASI PATH, a routine Special Issuance renewal may now be completed by the Aviation Medical Examiner (AME) instead of being sent back to the FAA for a new decision every cycle.
Bottom line: PATH can make follow-up certification faster and more predictable for stable, already-authorized cases. It does not allow an AME to approve a first-time Special Issuance, and it does not apply unless your current FAA Authorization letter specifically says “AASI PATH.”
What Is AASI PATH?
An AME Assisted Special Issuance allows an AME to reissue a medical certificate under an Authorization previously granted by the FAA. The FAA physician still makes the initial decision under 14 CFR § 67.401. Once the FAA determines that a case is appropriate for AME-assisted follow-up, the Authorization letter tells the AME exactly what must be reviewed before another certificate can be issued.
The new PATH protocol applies that model to certain Special Issuance or Special Consideration cases involving anxiety, depression, and related conditions. It shifts a stable renewal from a centralized FAA review to a structured review in the AME's office—provided every requirement is met and no new concern appears.
That distinction matters. PATH is a renewal pathway, not a first-application shortcut.
Who Can Use PATH?
The FAA's new PATH Status Summary begins with a direct instruction: if you do not already have a Special Issuance or Special Consideration, stop—the form does not apply.
To use this pathway, all of the following must be true:
- You already hold an FAA Special Issuance or Special Consideration for anxiety, depression, or a related condition;
- Your current Authorization letter specifically states that AASI PATH has been approved;
- You bring all required detailed clinical progress notes to the AME;
- Your treating clinician completes Section 1 of the PATH Status Summary;
- Your AME completes Section 2 after reviewing the form and your records; and
- There is no new “Yes” answer, significant interval worsening, or other clinical concern requiring deferral.
If your letter does not mention AASI PATH, continue following the exact requirements in your current Authorization. Do not assume that a previous antidepressant or mental-health Special Issuance has automatically moved into PATH.
Important: Industry reporting indicates that the FAA is reviewing existing antidepressant Special Issuance cases for possible PATH eligibility as those cases come up for review. That transition language is not a substitute for your individual Authorization. Until the FAA sends a letter placing you in PATH, your current letter remains the controlling instruction.
What Changed—and What Did Not
What changed
- Eligible renewals can be handled by the AME. A stable airman with an AASI PATH Authorization and complete documentation may be reissued in the office.
- The follow-up decision is more structured. The treating clinician and AME use a one-page status summary focused on clinical stability, function, safety, and new concerns.
- Routine renewal may become more predictable. When the file is complete and the answers remain favorable, the case does not need a fresh FAA decision at every renewal.
- Responsibility is shared. The airman, treating clinician, and AME each have a defined role in monitoring health and aviation safety.
What did not change
- The FAA still makes the initial Special Issuance decision. A first-time application must be deferred to the FAA's Aeromedical Certification Division (AMCD) or the appropriate Regional Flight Surgeon (RFS).
- PATH is not automatic. The words “AASI PATH” must appear in the Authorization.
- A deferral is still required when concerns arise. PATH gives the AME authority to reissue a stable case; it does not give the AME authority to overlook a change in condition.
- MedXPress reporting obligations remain. PATH does not change the requirement to answer FAA Form 8500-8 truthfully and completely.
- Your individual letter still controls. If the Authorization asks for additional records, evaluations, or monitoring, those requirements remain in effect.
The Documentation PATH Requires
The most preventable problem in FAA medical certification is incomplete documentation. PATH is simpler than sending every stable renewal back through the FAA, but it is not paperwork-free.
1. An Authorization approving AASI PATH
Bring the complete current Authorization letter—not an old letter, a portal screenshot, or a verbal summary. The AME needs to confirm that the FAA has approved AASI PATH and review any case-specific conditions.
2. All interim Detailed Clinical Progress Notes
The FAA's AASI PATH guidance establishes minimum note frequency:
- At least once each year: a detailed clinical progress note from a visit with the primary physician (MD or DO);
- Every six months: progress notes from the treating physician or an extender such as a PA-C or NP, or more often when clinically indicated; and
- Within 90 days of the AME exam: the most recent clinical progress note.
The notes must be genuinely detailed. The FAA expects an interim summary; current medications, doses, and side effects; medication changes; physical examination findings; results of testing; diagnosis; assessment and plan, including prognosis; and follow-up.
A short note saying “stable, continue medication” may not contain enough information. Give your treating clinician the FAA requirements before the visit so the necessary details are recorded in the actual progress note.
3. The completed PATH Status Summary
The treating clinician completes and signs Section 1. The AME then reviews that section and all interim progress notes, completes Section 2, signs the form, and uploads it and the progress notes to the FAA file.
The Four PATH Status Questions
The one-page worksheet reduces the renewal decision to four safety-focused questions covering the prior 12 months.
Questions 1 and 2: treating clinician
- Has there been any prolonged, clinically significant worsening in cognition, judgment, emotional stability, insight, or function?
- Have there been newly disclosed arrests, convictions, incarcerations, or significant episodes involving intense anger, hostility, threats, coercive or controlling behavior, stalking, domestic violence, significant impulsivity or risk-taking, assault, restraining orders, or other interpersonal violence?
Questions 3 and 4: AME
- Is there evidence of symptom exacerbation, functional decline, or clinical deterioration that raises concern about safely operating in the National Airspace?
- Does the AME have concerns after reviewing the records or using a standard screening tool for the condition?
If any answer falls in the “Yes” column—or there has been significant interval worsening or any other concern—the AME must defer the application to the FAA.
A deferral is not a denial. It means the AME cannot complete the renewal under the assisted pathway and the FAA must review the case. The difference is important, but so is preparation: a preventable documentation problem can still add substantial time.
Other Reasons the AME Must Defer
The AASI guidance also requires deferral when the psychiatrist, treating clinician, or AME identifies:
- New or previously unreported psychiatric symptoms, signs, or diagnoses;
- A new history of substance use disorder or FAA substance dependence;
- Progression of the condition—meaning symptoms persist despite changes to medication and/or therapy; or
- Any other concern held by the AME or treating provider.
The worksheet also reinforces the airman's existing responsibility to self-ground when a medical deficiency makes flight unsafe. If significant deterioration affects cognition, judgment, emotional stability, or insight and the individual lacks awareness to stop safety-sensitive duties, the clinician or AME is instructed to notify the FAA.
PATH Is Different From the Anxiety/Depression Fast Track
The names can be confusing because the FAA now has several mental-health pathways.
The Anxiety/Depression Fast Track helps the FAA and AME evaluate certain current or previously deferred cases that may qualify under the FAA's disposition table. AASI PATH, by contrast, governs follow-up reissuance after the FAA has already granted an Authorization and specifically placed the case in PATH.
A pilot should not select a form based only on a diagnosis. The correct route depends on the history, current treatment, medication use, clinical stability, and—when a Special Issuance already exists—the exact wording of the FAA Authorization.
How to Prepare for a PATH Renewal
- Read your Authorization letter early. Confirm that it says AASI PATH and note every case-specific requirement.
- Schedule the treating-clinician visit in time. Your newest detailed progress note must be no more than 90 days old at the AME exam.
- Give the clinician the FAA documents before the appointment. This helps prevent a brief office note that omits required information.
- Collect every interim note. Do not bring only the newest visit if the Authorization requires the entire interval.
- Have the clinician complete Section 1. Make sure the form is signed and dated.
- Send the packet to your AME for pre-review. Do not wait until the day of the flight physical to discover a missing record.
- Report changes honestly. New symptoms or concerns do not automatically equal permanent loss of certification, but hiding them can create a far more serious certification problem.
What This Means for Pilots
PATH is a positive move toward risk-based, individualized mental-health certification. It recognizes that a pilot with an established diagnosis, effective treatment, sustained stability, and good clinical follow-up may not need the FAA to personally remake the same decision at every renewal.
It should also reduce uncertainty for some airmen. The standards are visible: keep the Authorization current, maintain complete clinical follow-up, use the status worksheet, and return the case to the FAA when the facts change.
But the benefit depends on getting the details right. The most important question is not simply, “Do I have anxiety or depression?” It is, “Which FAA pathway applies to my exact history, and what does my current Authorization require?”
How Go Flight Medicine Can Help
Our HIMS and aviation-medicine team helps pilots interpret FAA Authorization letters, organize the required records, coordinate with treating clinicians, and identify missing documentation before the AME exam. For pilots who are not yet in PATH, we can also help determine whether the case belongs in an immediate-issuance, Fast Track, traditional Special Issuance, or HIMS pathway.
Do not change your monitoring plan or submit a new application based only on a headline. Schedule a confidential consultation so we can review your history and the exact language in your FAA letter.
References and Further Reading
- FAA Guide for Aviation Medical Examiners — AASI for Anxiety, Depression, and Related Conditions PATH (updated July 29, 2026)
- FAA — PATH Status Summary: Anxiety, Depression, and Related Conditions (updated July 29, 2026)
- FAA — Item 47: Anxiety, Depression, and Related Conditions
- AOPA — Special Issuance Certification for Depression with Antidepressant Usage
- Wingman Med — FAA AASI PATH for Pilots Taking Antidepressants
- AVweb — FAA Gives AMEs More Authority on Mental Health Medical Renewals
This article provides general educational information and is not a substitute for individualized medical or legal advice. FAA policies and individual Authorization requirements can change. Always follow your current FAA letter and consult a qualified AME about your specific case.